Equillium, Inc. (EQ)
NASDAQ: EQ · Real-Time Price · USD
2.050
+0.010 (0.49%)
At close: Apr 28, 2026, 4:00 PM EDT
2.012
-0.038 (-1.86%)
After-hours: Apr 28, 2026, 5:50 PM EDT
Equillium Market Cap
Equillium has a market cap or net worth of $129.61 million as of April 28, 2026. Its market cap has increased by 695.77% in one year.
Market Cap
129.61M
Enterprise Value
98.79M
1-Year Change
695.77%
Ranking
Category
Stock Price
$2.05
Market Cap Chart
Since October 12, 2018, Equillium's market cap has decreased from $234.54M to $129.61M, a decrease of -44.74%. That is a compound annual growth rate of -7.56%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 128.98M | 36.66% |
| Dec 31, 2025 | 94.38M | 256.04% |
| Dec 31, 2024 | 26.51M | 4.40% |
| Dec 29, 2023 | 25.39M | -30.27% |
| Dec 30, 2022 | 36.41M | -67.14% |
| Dec 31, 2021 | 110.80M | -16.24% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Oct 12, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Alpha Cognition | 141.31M |
| TuHURA Biosciences | 141.14M |
| Connect Biopharma Holdings | 138.48M |
| Kalaris Therapeutics | 138.03M |
| Kazia Therapeutics | 136.55M |
| Immunic | 129.62M |
| Innate Pharma | 127.25M |
| Biomea Fusion | 125.08M |